Cover Image

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis

Background: The present study aimed to address the effect of Rituximab on the cognitive impairment in patients with secondary progressive MS (SPMS). Methods: The present interventional study used a convenience sampling method to select the study participants from SPMS patients. All these patients ha...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saeideh Salehizadeh (Author), Roghayeh Saeidi (Author), Mohammad Ali Sahraian (Author), Hossein Rezaei Aliabadi (Author), Seyedeh Nafiseh Hashemi (Author), Sharareh Sharareh (Author), Mohammad Reza Gheini (Author), Shaghayegh Shahmirzaei (Author), Mahsa Owji (Author), Abdorreza Naser Moghadasi (Author)
Format:	Book
Published:	Babol University of Medical Sciences, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
by: Mohammad Ali Sahraian, et al.
Published: (2020)

The Effect of Ginseng on Fatigue Related to Neuromyelitis Optica Spectrum Disorder: A Double-Blinded Randomized controlled Clinical Trial
by: Sara Aslzadeh, et al.
Published: (2024)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
by: Mahsa Ghajarzadeh, et al.
Published: (2014)

Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
by: Maral Seyed Ahadi, et al.
Published: (2020)

Computerized cognitive rehabilitation in patients with multiple sclerosis (MS): A systematic review and meta-analysis
by: Abdorreza Naser Moghadasi, et al.
Published: (2025)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
by: Mahsa Arzani, et al.
Published: (2018)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
by: Sharareh ESKANDARIEH, et al.
Published: (2017)

Multiple sclerosis in parsis: a historical issue.
by: Abdorreza Naser Moghadasi
Published: (2014)

Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study
by: Hoda Kamali, et al.
Published: (2022)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
by: Abdorreza Naser Moghadasi
Published: (2021)

Clinical Evaluation of 38 Patients with Juvenile Myoclonic Epilepsy.
by: Abdorreza Naser Moghadasi, et al.
Published: (2014)

Beyond the division of multiple sclerosis into different subgroups: The Concept of Connectomopathy
by: Abdorreza Naser Moghadasi, et al.
Published: (2024)

Psychometric properties of the Persian version of emotions and attitudes towards MRI" (MRI-EMA)
by: Abdorreza Naser Moghadasi, et al.
Published: (2023)

Obsessive Compulsive Disorder as a Presenting Symptom of COVID-19: A case-series from Iran
by: Mahsa Owji, et al.
Published: (2022)

Comparing the Safety and Efficacy of Ziferon and Betaferon in Patients With Remitting-Relapsing Multiple Sclerosis
by: Mohammad Reza Gheini, et al.
Published: (2019)

Effects of robotic rehabilitation on fatigue experience, disability, and quality of life in patients with multiple sclerosis (MS): A systematic review and meta-analysis
by: Abdorreza Naser moghadasi, et al.
Published: (2024)

Effect of vitamin A on recovery from the acute phase of multiple sclerosis-related optic neuritis, double-blind, randomized, placebo-controlled trial
by: Shiva Rahimi-Dehgolan, et al.
Published: (2023)

Development, and evaluation of drug monitoring system for multiple sclerosis patients
by: Reza Safdari, et al.
Published: (2021)

Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
by: Maral Seyed Ahadi, et al.
Published: (2021)

De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: the initial Iranian experience
by: Sepideh Paybast, et al.
Published: (2025)

Disease Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
by: Negar Molazadeh, et al.
Published: (2023)

Tragedy of rostam and sohrab: first example introducing the science of mytho-pathology.
by: Abdorreza Naser Moghadasi
Published: (2014)

The Burnt City and the Evolution of the Concept of "Probability" In the Human Brain
by: Abdorreza NASER MOGHADASI
Published: (2015)

Agnosia in Canon: a Historical Issue.
by: Abdorreza Naser Moghadasi
Published: (2014)

Artificial Eye in Burnt City and Theoretical Understanding of How Vision Works.
by: Abdorreza Naser Moghadasi
Published: (2014)

First Visual Evidence of Leprosy in the Continental Shelf of Iran
by: Abdorreza NASER-MOGHADASI
Published: (2015)

First Skull Surgery in Iran: The Burned City and a 4800-Year-Old Skull.
by: Abdorreza Naser Moghadasi
Published: (2014)

Pediatric Neuromyelitis Optica Spectrum Disorders: Three Case Reports and Review of Literature
by: Seyed Mohammad Baghbanian, et al.
Published: (2020)

Recommendations for a Better Control of Seizures in Epileptic Patients
by: Saeideh SALEHIZADEH
Published: (2020)

Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis
by: George Vartzelis, et al.
Published: (2019)

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
by: Mehdi Rezaee, et al.
Published: (2022)

Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder
by: Seyed Mohammad Forouzannia, et al.
Published: (2021)

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
by: Tobias Zrzavy, et al.
Published: (2021)

Lived experience of health care providers about preconception care for diabetic women
by: Nafiseh Sadat Nekuei, et al.
Published: (2010)

Efficacy and safety of "Jollab Monzej" as a traditional persian compound medicine for the treatment of multiple sclerosis-related fatigue: A randomized placebo-controlled trial
by: Fatemeh Yousefnia Babaki, et al.
Published: (2023)

Corrigendum to "Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis"
Published: (2021)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
by: Rozita Doosti, et al.
Published: (2021)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
by: Saharat Aungsumart, et al.
Published: (2023)

NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy
by: Simone Dal Bello, et al.
Published: (2024)

Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia
by: Mansour A. Alharbi, et al.
Published: (2023)